title: Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature.
abstract: Kodamaea (Pichia) ohmeri is an unusual yeast-form fungus that has recently been identified as an important etiology of fungemia, endocarditis, cellulitis, funguria and peritonitis in immunocompromised patients. We report a case of K. ohmeri fungemia in a 34-year-old hospitalized patient with thrombophlebitis. The patient was admitted to the hospital for evaluation and management of an acquired tracheo-esophageal fistula secondary to an impacted denture. Fever developed on hospital day 22, and physical exam revealed right arm superficial thrombophlebitis at the site of the peripheral venous catheter that was confirmed by Doppler ultrasound. The peripheral vein was removed and blood cultures from hospital day 22 and 23 grew yeast species. The yeast was subsequently identified to be K. ohmeri by Vitek II and API20C and was confirmed by 18S rRNA gene sequencing. The fungemia and right arm phlebitis was successfully treated with a 2-week course of micafungin therapy. This is the first case of K. ohmeri fungemia in a patient that was successfully treated with micafungin.
authors.affiliation: Infectious Diseases, St Michael's Medical Center, 111 Central Avenue, Newark, NJ 07102, USA. hamidshaaban@gmail.com
authors.forename: Hamid
authors.initials: H
authors.lastname: Shaaban
authors.forename: Hoo Feng
authors.initials: HF
authors.lastname: Choo
authors.forename: Jack
authors.initials: J
authors.lastname: Boghossian
authors.forename: George
authors.initials: G
authors.lastname: Perez
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D055499:Catheter-Related Infections / Q000150:complications / Q000175:diagnosis; D004271:DNA, Fungal / Q000737:chemistry / Q000235:genetics; D004275:DNA, Ribosomal / Q000737:chemistry / Q000235:genetics; D003778:Dentures / Q000009:adverse effects; D054714:Echinocandins / Q000627:therapeutic use*; D016469:Fungemia / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D020459:Genes, rRNA; D006801:Humans; D055666:Lipopeptides / Q000627:therapeutic use*; D008297:Male; D000077551:Micafungin; D016533:Mycological Typing Techniques; D012331:RNA, Fungal / Q000235:genetics; D012335:RNA, Ribosomal / Q000235:genetics; D004718:Saccharomycetales / Q000145:classification / Q000302:isolation & purification*; D017422:Sequence Analysis, DNA; D013924:Thrombophlebitis / Q000150:complications / Q000175:diagnosis; D014138:Tracheoesophageal Fistula / Q000150:complications
chemical_list: D000935:Antifungal Agents; D004271:DNA, Fungal; D004275:DNA, Ribosomal; D054714:Echinocandins; D055666:Lipopeptides; D012331:RNA, Fungal; D012335:RNA, Ribosomal; C065096:RNA, ribosomal, 26S; D000077551:Micafungin
references.citation: Mycoses. 2005 Jul;48(4):265-9
references.pmid: 15982209
references.citation: Int J Infect Dis. 2009 Nov;13(6):e493-7
references.pmid: 19411182
references.citation: Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):127-30
references.pmid: 14722784
references.citation: Perit Dial Int. 2000 Jan-Feb;20(1):91
references.pmid: 10716592
references.citation: Biosci Biotechnol Biochem. 1995 Jun;59(6):1172-4
references.pmid: 7613010
references.citation: J Infect Chemother. 2003 Mar;9(1):88-9
references.pmid: 12673414
references.citation: Ann Intern Med. 1985 Jan;102(1):67-8
references.pmid: 3966747
references.citation: Scand J Infect Dis. 2002;34(2):140-1
references.pmid: 11928850
references.citation: Med Mycol. 2009 Nov;47(7):775-9
references.pmid: 19888811
references.citation: Kidney Int. 2001 Oct;60(4):1452-9
references.pmid: 11576359
references.citation: J Antimicrob Chemother. 2003 Oct;52(4):679-82
references.pmid: 12951345
references.citation: J Med Microbiol. 2006 Feb;55(Pt 2):237-239
references.pmid: 16434718
references.citation: J Clin Microbiol. 2007 Mar;45(3):1005-10
references.pmid: 17251396
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3149-54
references.pmid: 14506023
references.citation: Leuk Lymphoma. 2006 Sep;47(9):1949-51
references.pmid: 17065010
references.citation: Am J Med. 2001 Nov;111(7):528-34
references.pmid: 11705428
references.citation: Eur J Clin Microbiol Infect Dis. 2000 Dec;19(12):971-3
references.pmid: 11205641
references.citation: J Hosp Infect. 2002 May;51(1):75-7
references.pmid: 12009828
references.citation: Diagn Microbiol Infect Dis. 1998 Mar;30(3):229-31
references.pmid: 9572030
references.citation: Rev Iberoam Micol. 2007 Jun;24(2):155-6
references.pmid: 17604437
references.citation: Eur J Clin Microbiol Infect Dis. 2002 Aug;21(8):630-1
references.pmid: 12226699
references.citation: Pathology. 2008 Jan;40(1):99-101
references.pmid: 18038331
references.citation: Heart Vessels. 2002 Sep;16(6):260-3
references.pmid: 12382036
references.citation: Int J Antimicrob Agents. 2010 Jan;35(1):98-9
references.pmid: 19896340